Thalidomide-O-amido-C6-NH2 TFA rchlorate InChi: InChI=1S/C22H30FN3O7/c1-13(2)19(26-22(31)33-12-15-8-6-5-7-9-15)21(30)24-14(3)20(29)25-16(17(27)11-23)10-18(28)32-4/h5-9

InChi: InChI=1S/C22H30FN3O7/c1-13(2)19(26-22(31)33-12-15-8-6-5-7-9-15)21(30)24-14(3)20(29)25-16(17(27)11-23)10-18(28)32-4/h5-9

Smiles: NC(=O)C1C=CC=C2NC(=NC=12)C1=CC=C(C=C1F)[C@@H]1CCCN1

BCR-ABL has been developed

33)34)10-15(17)19(32)31-7-5-30(6-8-31)18-16(22)9-13(11-29-18)21(26

Profile of entrectinib and its potential in the treatment of ROS1-positive NSCLC: evidence to date

Thalidomide-O-amido-C6-NH2 TFA rchlorate InChi: InChI=1S/C22H30FN3O7/c1-13(2)19(26-22(31)33-12-15-8-6-5-7-9-15)21(30)24-14(3)20(29)25-16(17(27)11-23)10-18(28)32-4/h5-9Thalidomide O amido C6 NH2 TFA (Cereblon Ligand Linker Conjugates 11 TFA), a synthesized E3 ligase ligand linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker, can be used in the synthesis of PROTACs. Product information CAS Number: 1950635 14 9 Molecular Weight: 544. 48 Formula: C23H27F3N4O8 Chemical Name: N (6 aminohexyl) 2 {[2 (2,6 dioxopiperidin 3 yl) 1,3 dioxo 2,3 dihydro 1H isoindol 4 yl]oxy}acetamide;